o-Toluoyl Chloride CAS 933-88-0 Uruganda rwagati rwa Tolvaptan
Gutanga ibicuruzwa, Ubwiza buhanitse, Umusaruro wubucuruzi
Tolvaptan hamwe nabahuza:
Tolvaptan CAS 150683-30-0
7-Chloro-1,2,3,4-tetrahydrobenzo [b] azepin-5-imwe CAS 160129-45-3
o-Toluoyl Chloride CAS 933-88-0
4-Amino-2-Acide Methylbenzoic CAS 2486-75-1
2-Methyl-4-Acide Nitrobenzoic CAS 1975-51-5
Izina ryimiti | o-Toluoyl Chloride |
Synonyme | 2-Methylbenzoyl Chloride |
Numero ya CAS | 933-88-0 |
Inomero y'injangwe | RF-PI396 |
Imiterere yimigabane | Mububiko, Igipimo cyumusaruro kugeza kuri Toni |
Inzira ya molekulari | C8H7ClO |
Uburemere bwa molekile | 154.59 |
Ingingo yo gushonga | 159.5-160.9 ℃ |
Ingingo yo guteka | 88.0 ~ 90.0 ℃ / 12 mmHg (lit.) |
Ubucucike | 1.185 g / mL kuri 25 ℃ (lit.) |
Ironderero | n20 / D 1.5549 (lit.) |
Amazi meza | Igisubizo n'amazi |
Ikirango | Ruifu |
Ingingo | Ibisobanuro |
Kugaragara | Ibara ritagira ibara |
Suzuma | ≥99.0% |
Benzoyl Chloride | ≤0.30% |
M & P-Methyl Benzoyl Chloride | ≤0.50% |
O-Toluic Acide | ≤0.50% |
Ibindi Bidasobanutse neza | 20,20% |
Impanuka zose | ≤1.0% |
Gutakaza Kuma | ≤0.50% |
Ikizamini | Ibipimo ngenderwaho |
Ikoreshwa | Imiti ya farumasi |
Amapaki: Icupa, 25kg / Barrale cyangwa 180kg Ingoma ya plastike, cyangwa ukurikije ibyo umukiriya asabwa.
Imiterere yo kubika:Bika mu bikoresho bifunze ahantu hakonje kandi humye;Irinde urumuri nubushuhe.


o-Toluoyl Chloride (CAS 933-88-0) ikoreshwa nka farumasi.o-Toluoyl Chloride ikoreshwa muri synthesis niba ibinini bya quinolinone nka SARS CoV 3CLpro inhibitor.Ikoreshwa kandi muri synthesis ya benzooxaboroles nkibikoresho byo mu kanwa birwanya inflammatory.o-Toluoyl Chloride ni intera ya Tolvaptan (CAS 150683-30-0) yo kuvura hyponatremia.Tolvaptan, izwi kandi ku izina rya OPC-41061, ni uburyo bwo guhitamo, guhatanira arginine vasopressin reseptor 2 antagonist ikoreshwa mu kuvura hyponatremia (urugero rwa sodium nkeya mu maraso) ifitanye isano no kunanirwa k'umutima, cirrhose, hamwe na syndrome ya hormone idakwiye (SIADH).Otsuka Pharmaceutical yemereye tolvaptan ku izina ryubucuruzi Samsca nyuma yuko FDA yemeye ibiyobyabwenge muri Gicurasi 2009.